Skip to main content
TipRanks
Go Ultimate75% OFF

Regenerative Medical Technology Group (RMTG) Stock Price & Analysis

6 Followers

RMTG Stock Chart & Stats

$0.03$0.00(0.00%)
At close: 4:00 PM EST
$0.025$0.05$0.075$0.1Aug 18Aug 31Sep 14Sep 28Oct 12Oct 26Nov 11
Day’s Range
$0.03 - $0.03
52-Week Range
$0.02 - $0.13
Previous Close
$0.03
Volume
N/A
Average Volume (3M)
40.39K
Market Cap
$412.17K
Enterprise Value
$21.03M
Total Cash (Recent Filing)
$1.32M
Total Debt (Recent Filing)
$21.74M
Price to Earnings (P/E)
―
Beta
-1.53
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Revenue Growth

Rapid revenue expansion demonstrates meaningful demand for the company’s regenerative medicine offerings and provides a larger base over which fixed costs can be absorbed. If sustained, this momentum could improve operating leverage and support broader market development.

Solid Gross Economics

A gross margin near 60% indicates that the products and services generate useful contribution after direct costs. The move to slightly positive EBIT also suggests improving operating discipline, although continued scale and cost control are needed to convert this into durable profitability.

Scalable Commercial Platform

The combination of education, product sales, clinical activity, and physician training creates multiple routes to customer acquisition and recurring demand. Management’s focus on higher-margin products, affiliate revenue, and network expansion could strengthen the business model as adoption grows.

Bears Say

Stressed Balance Sheet

Negative equity and debt that is large relative to assets leave the company with little financial cushion for creditors or shareholders. This stressed capital structure can constrain investment, increase dependence on financing, and make balance-sheet repair a multi-quarter priority.

Persistent Net Losses

The company’s gross profit and improved EBIT have not yet translated into bottom-line earnings, with losses still exceeding revenue by a substantial amount. Continued net losses can consume capital, delay self-funding, and weaken the ability to finance expansion without outside support.

Negative Free Cash Flow

Negative free cash flow means current operations are not yet funding capital spending and growth requirements. Even with a modest improvement in operating cash flow, ongoing cash burn may require continued external financing and limits flexibility to address liabilities or invest selectively.

Regenerative Medical Technology Group News

RMTG FAQ

What was Regenerative Medical Technology Group’s price range in the past 12 months?
Regenerative Medical Technology Group lowest stock price was $0.02 and its highest was $0.13 in the past 12 months.
What is Regenerative Medical Technology Group’s market cap?
Regenerative Medical Technology Group’s market cap is $412.17K.
When is Regenerative Medical Technology Group’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Regenerative Medical Technology Group’s earnings last quarter?
Regenerative Medical Technology Group released its earnings results on Aug 20, 2026. The company reported -$0.22 earnings per share for the quarter.
Is Regenerative Medical Technology Group overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Regenerative Medical Technology Group pay dividends?
Regenerative Medical Technology Group does not currently pay dividends.
What is Regenerative Medical Technology Group’s EPS estimate?
Regenerative Medical Technology Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Regenerative Medical Technology Group have?
Regenerative Medical Technology Group has 13,738,968 shares outstanding.
What happened to Regenerative Medical Technology Group’s price movement after its last earnings report?
Regenerative Medical Technology Group reported an EPS of -$0.22 in its last earnings report. Following the earnings report the stock price went up 18.644%.
Which hedge fund is a major shareholder of Regenerative Medical Technology Group?
Currently, no hedge funds are holding shares in RMTG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology